相关实验视频
Updated: Feb 20, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.9K
在美国人中肥胖的流行率 有或没有残疾的成年人
Cheryl D Fryar1, Julie D Weeks2, Catharine A Couch1
1Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland, USA.
Obesity (Silver Spring, Md.)
|February 18, 2026
概括
有残疾的成年人比没有残疾的成年人患肥胖率更高,即使考虑到各种因素. 这突显了残疾人群体的重大公共卫生问题.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 关于残疾人的研究.
背景情况:
- 肥胖是一个主要的公共卫生问题,对健康有重大影响.
- 了解包括残疾人在内的不同人口子组中肥胖的流行率对于有针对性的干预至关重要.
研究的目的:
- 提供当前的,全国代表性的美国成年人中肥胖的流行率估计,残疾和没有残疾.
- 检查成年人口中肥胖和残疾状况之间的关联.
主要方法:
- 利用了来自国家健康和营养检查调查 (2021年8月-2023年8月) 的5917名成年人 (年龄≥20岁) 的数据.
- 使用测量身体质量指数 (BMI) ≥30.0来定义肥胖. 基于自我报告的功能困难定义的残疾.
- 使用后勤回归模型,调整社会人口统计学,行为和健康状况变量,以评估肥胖-残疾相关性.
主要成果:
- 总体而言,40.3%的成年人患有肥胖症,16.5%的人报告有残疾.
- 与没有 (37.9%) 相比,残疾成年人呈现出更高的年龄调整肥胖患病率 (50.6%).
- 即使对多种因素进行调整后,残疾成年人中肥胖仍然比较普遍 (调整后的患病率=1.14).
结论:
- 在残疾成年人中观察到的更高的肥胖率并不能通过年龄,性别,种族-西班牙裔,教育,吸烟或健康状况的差异来解释.
- 调查结果强调了肥胖率的持续差异,强调了为残疾人制定量身定制的公共卫生战略的必要性.
相关概念视频
Drug Dosing: Obese Patients
279
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
208
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
208
Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Prevalence and Incidence
2.0K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.0K

